Arkolith/Insider Trading/XFOR/Form 4

Stewart Murray

Interim Chief Medical Officer, DirectorX4 Pharmaceuticals, Inc (XFOR) · full profile →Form 4 · filed Aug 11, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$138K
Net Open-Market Flow
-$138K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 10, 2023Sell(S)130K$1.06$138K147K
Aug 9, 2023Grant(A)270K—$0277K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-23-029148) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML